Health Care & Life Sciences » Biotechnology | CrystalGenomics Inc.

CrystalGenomics Inc.

CrystalGenomics Inc.
Stock Exchange Korea Exchange
EPS
KRW92.33
Market Cap
KRW887.53 B
Shares Outstanding
39.62 M
Public Float
32.01 M

Profile

Address
5/F, Tower A, Korea Bio Park
Seongnam GY 13488
Korea, Republic Of
Employees -
Website http://www.crystalgenomics.com
Updated 09/14/2018
CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company operates through following business divisions: Research and Development, New Drug Development division, New Drug Sales, Products Sales, and Real Estate Leasing. The Research and Development division provides analysis of clinical trials services.

Financials

View All

Joong-Myung Cho
Chief Executive Officer & Director
In-Cheol Jung
Chief Financial Officer & Director